Stay updated on Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a new publication reference under Publications: Chan ATC, Lee VHF, Hong RL, et al. Analysis of Plasma Epstein-Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE-122 (Cancer Med. 2026;15(2):e71496, DOI: 10.1002/cam4.71496). The entry notes that publications are auto-filled from PubMed and includes a Revision: v3.4.2.
    Difference
    0.6%
    Check dated 2026-02-11T14:11:56.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide government funding notice and a new Revision: v3.4.1 tag, and removed the previous Revision: v3.4.0 tag.
    Difference
    0.4%
    Check dated 2026-02-04T10:21:56.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Show glossary feature added and metadata labels updated (including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data') with capitalization/style tweaks, and revision updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:56:16.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision history updated: v3.3.4 was added and v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:40:42.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Footer updates include Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link; the rest of the page content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T20:56:14.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Added a note clarifying that publications are provided voluntarily and updated the revision to v3.3.2. Removed the previous note about publications relating to the study results, which referred to revision v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T10:41:13.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial page.